{
    "Trade/Device Name(s)": [
        "cobas\u00ae Factor II and Factor V Test"
    ],
    "Submitter Information": "Roche Molecular Systems, Inc.",
    "510(k) Number": "K172913",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033612",
        "K033607"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NPR",
        "NPQ"
    ],
    "Summary Letter Date": "December 13, 2017",
    "Summary Letter Received Date": "December 14, 2017",
    "Submission Date": "September 13, 2017",
    "Regulation Number(s)": [
        "21 CFR 864.7280"
    ],
    "Regulation Name(s)": [
        "Factor V Leiden DNA mutation detection systems"
    ],
    "Analyte Class(es)": [
        "genetic molecular",
        "hematology"
    ],
    "Analyte(s)": [
        "Factor II (Prothrombin) G20210A mutation",
        "Factor V Leiden G1691A mutation"
    ],
    "Specimen Type(s)": [
        "Whole Blood",
        "Genomic DNA"
    ],
    "Specimen Container(s)": [
        "K2EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas\u00ae z 480 analyzer",
        "cobas\u00ae 4800 System CU"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Multiplex PCR"
    ],
    "Methodologies": [
        "Genotyping",
        "DNA mutation detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Reagent",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for cobas\u00ae Factor II and Factor V Test, a multiplex real-time PCR assay for genotyping Factor II and Factor V mutations related to thrombophilia",
    "Indications for Use Summary": "For qualitative detection and genotyping of Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations in genomic DNA from K2EDTA whole blood specimens to aid in the diagnosis of patients with suspected thrombophilia",
    "fda_folder": "Hematology"
}